A916: rectum: adenocarcinoma

Similar documents
Colorectal Cancer Structured Pathology Reporting Proforma DD MM YYYY

11/21/13 CEA: 1.7 WNL

8. The polyp in the illustration can be described as (circle all that apply) a. Exophytic b. Pedunculated c. Sessile d. Frank

Colon and Rectum. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6th edition

Gastric Cancer Histopathology Reporting Proforma

LOINC. Clinical information. RCPA code. Record if different to report header Operating surgeon name and contact details. Absent.

Case presentation. Eran Zittan. MD Mount Sinai Hospital, Toronto, Canada. Emek Medical Center, Afula, Israel. March, 2016

Staging Challenges in Lower GI Cancers. Disclosure of Relevant Financial Relationships. AJCC 8 th edition and CAP protocol updates

Tumours of the Oesophagus & Gastro-Oesophageal Junction Histopathology Reporting Proforma

2014/2015 FCDS Educational Webcast Series

Alison Douglass Gillian Lieberman, MD. November. Colon Cancer. Alison Douglass, Harvard Medical School Year III Gillian Lieberman, MD

A218 : Esophagus cancer tissues. (formalin fixed)

[A RESEARCH COORDINATOR S GUIDE]

Colon and Rectum 5/1/14

A103(9)- Normal tissues, more than single spots

The Rodger C. Haggitt Memorial Lecture

Collaborative Stage for TNM 7 - Revised 06/30/2008 [ Schema ]

Navigators Lead the Way

Small Intestine. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition

A215- Urinary bladder cancer tissues

Overview. Collecting Cancer Data: Colon 11/5/2009. Collecting Cancer Data: NAACCR Webinar Series 1. Agenda NAACCR WEBINAR SERIES

Rectal Cancer Cookbook Update. A. JOURET-MOURIN with the collaboration of A Hoorens,P Demetter, G De Hertogh,C Cuvelier and C Sempoux

Neoplasms of the Colon and of the Rectum

AJCC 7 th Edition Staging Disease Site Webinar Colorectum

7 th Edition Staging. AJCC 7 th Edition Staging. Disease Site Webinar. Colorectum. Overview. This webinar is sponsored by

Colorectal adenocarcinoma leading cancer in developed countries In US, annual deaths due to colorectal adenocarcinoma 57,000.

Outline. Colon and Rectal Cancers. Overview. Overview. Anatomic Distribution. Incidence and Mortality 12/12/2013

Joseph Misdraji, M.D. GI pathology Unit Massachusetts General Hospital

Colon and Rectal Cancers. Outline. Overview 12/12/2013. FCDS Educational Webcast Series December 12, 2013

ADVANCES IN COLORECTAL CANCERS IS THERE HOPE? Dr Lim Hwee Yong Medical Oncologist

SEER EOD AND SUMMARY STAGE ABSTRACTORS TRAINING

Colon and Rectum. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6th edition

Seventh Edition Staging 2017 Colorectum. Overview. This webinar is sponsored by. the Centers for Disease Control and Prevention.

Imaging in gastric cancer

IMAGING GUIDELINES - COLORECTAL CANCER

COLORECTAL CANCER FAISALGHANISIDDIQUI MBBS; FCPS; PGDIP-BIOETHICS; MCPS-HPE

Imaging Evaluation of Polyps. CT Colonography: Sessile Adenoma. Polyps, DALMs & Megacolon Objectives

Carcinoma of the Renal Pelvis and Ureter Histopathology

Handling & Grossing of Colo-rectal Specimens for Tumours. for Medical Officers in Pathology

Neoplastic Colon Polyps. Joyce Au SUNY Downstate Grand Rounds, October 18, 2012

Quiz. b. 4 High grade c. 9 Unknown

Update on staging colorectal carcinoma, the 8 th edition AJCC. General overview of staging. When is staging required? 11/1/2017

Protocol for the Examination of Specimens From Patients With Primary Carcinoma of the Colon and Rectum

Small Intestine Cancer Early Detection, Diagnosis, and Staging

Colorectal Pathway Board (Clinical Subgroup): Imaging Guidelines September 2015

AJCC Cancer Staging 8 th Edition

(formalin fixed) 6 non-neoplastic spots (6 spots) Corresponding normal tissues with cancers: Yes Diameter: 1. 0 mm

References. GI Biopsies. What Should Pathologists Assistants Know About Gastrointestinal Histopathology? James M Crawford, MD, PhD

Greater Manchester & Cheshire Guidelines for Pathology Reporting for Oesophageal and Gastric Malignancy

Carcinoma of the Urinary Bladder Histopathology

Gastric Cancer in a Young Postpartum Female. Kings County Hospital Center SUNY Downstate Case Conference May 24, 2012

A superficial radiotherapy B single pass curettage C excision with 2 mm margins D excision with 5 mm margins E Mohs micrographic surgery.

Preoperative Data Colorectal Cancer Database

A301 VI- Various cancer tissues with corresponding normal tissues

COLON CANCER CARE GUIDELINES NON-METASTATIC DISEASE

Early colorectal cancer Quality and rules for a good pathology report Histoprognostic factors

Definition of Synoptic Reporting

Patologia sistematica V Gastroenterologia Prof. Stefano Fiorucci. Colon polyps. Colorectal cancer

Locally Advanced Colon Cancer. Feiran Lou MD. MS. Richmond University Medical Center Department of Surgery

Gastric (Stomach) Cancer

Case Scenario 1. The patient has now completed his neoadjuvant chemoradiation and has been cleared for surgery.

2018 Updates for Neoplasms of the Appendix, Colon, Rectum and GI NETs

Protocol for the Examination of Specimens from Patients with Primary Carcinoma of the Colon and Rectum

Protocol for the Examination of Specimens From Patients With Primary Carcinoma of the Colon and Rectum

Gastric Cancer Staging AJCC eighth edition. Duncan McLeod Westmead Hospital, NSW

Quiz Adenocarcinoma of the distal stomach has been increasing in the last 20 years. a. True b. False

Clinical Colon Cancer Abby Siegel MD COLON CANCER. 1. Epidemiology 2. Risk factors 3. Manifestations 4. Treatment

Wendy L Frankel. Chair and Distinguished Professor

Understanding Your Pathology Report

LUNG STAGING FORM LATERALITY: LEFT RIGHT BILATERAL

colorectal cancer Colorectal cancer hereditary sporadic Familial 1/12/2018

Physician s Cognitive and Communication Failures Result in Cancer Treatment Delay

Diagnostic Difficulties Encountered Among Colorectal Polyps

A220: Larynx cancer tissues. (formalin fixed)

Guide to Colorectal Cancer

UICC TNM 8 th Edition Errata

Colon Cancer Prediction based on Artificial Neural Network

Large Colorectal Adenomas An Approach to Pathologic Evaluation

FCDS March 2002 MONTHLY MEMO

Colon and Rectal Cancer. Treatment Guidelines for Patients

Case Presentation, Discussion and Sharing of Information on Unresectable Colon Cancer

Colon and Rectum (Sarcomas, lymphomas, and carcinoid tumors of the large intestine are not included)

Ritu Nayar, MD Professor and Vice Chair of Pathology Northwestern University, Feinberg School of Medicine Chicago, IL

malignant polyp Daily Challenges in Digestive Endoscopy for Endoscopists and Endoscopy Nurses BSGIE Annual Meeting 18/09/2014 Mechelen

Cervical cancer presentation

46. Merkel Cell Carcinoma

UICC TNM 8 th Edition Errata

Supplementary Appendix

Patient. Male 76 year old C.C: abdominal pain

Case Scenario year-old white male presented to personal physician with dyspepsia with reflux.

Incidence and Multiplicities of Adenomatous Polyps in TNM Stage I Colorectal Cancer in Korea

Proposed All Wales Vulval Cancer Guidelines. Dr Amanda Tristram

Protocol for the Examination of Specimens from Patients with Primary Carcinomas of the Colon and Rectum

Colon, Rectum, and Appendix. Presentation Outline. Overview Tumor Characteristics

Colon, Rectum, and Appendix

Staging of rectal cancer on MRI: What the surgeons want to know.

Disclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None

Molly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010

Transcription:

General facts of colorectal cancer The colon has cecum, ascending, transverse, descending and sigmoid colon sections. Cancer can start in any of the r sections or in the rectum. The wall of each of these sections (and rectum) has several layers of tissues. Cancer starts in the inner layer and can grow through some or all of the other layers. Knowing a little about these layers is helpful because the stage (extent of spread) of a cancer depends to a great degree on which of these layers it affects. Cancer that starts in the different areas may cause different symptoms. Colon and rectum cancers probably develop slowly over a period of several years. We now know that most of these cancers begin as a polyp--a growth of tissue into the center of the colon or rectum. Polyps are also known as adenomas. Removing the polyp early may prevent it from becoming cancer. Over 95% of colon and rectal cancers are adenocarcinomas. These are cancers of the cells that line the inside of the colon and rectum. There are some other, more rare, types of tumors of the colon and rectum, but the facts given here refer only to adenocarcinomas. Colon and rectal cancer have many features in common and are often referred to together as colorectal cancer. Treatment Surgery is the main treatment for cancer of the large bowel. It may be used either alone, or in combination with radiotherapy and chemotherapy. The treatment will depend on the stage of the cancer (its position, size and whether it has spread). This is decided through the results of various tests and what is discovered during surgery. Sometimes doctor may advise other treatment before surgery. This is because the results of the tests and scans have already given the doctor a good idea of the stage of the cancer. Many people need to have surgery to remove the cancer. If the cancer is an early stage (Dukes A= Stage I), the aim of surgery is to completely remove the cancer, and this may cure it. In situations where the cancer is advanced and causing a blockage (obstruction) of the bowel, surgery may be used to remove this. This will not cure the cancer, but can relieve symptoms. Chemotherapy is often given after surgery to try to reduce the chances of the cancer coming back. It is also given when the cancer is advanced and has spread to other parts of the body. In some people, both radiotherapy and chemotherapy are combined and given together before surgery is carried out. This is called chemoradioation. Radiotherapy is usually only used to treat cancer of the rectum and can be given before or after surgery. http://reference.allrefer.com/encyclopedia/

Primary tumor (T) Staging of colorectal cancer TX: Primary tumor cannot be assessed T0: No evidence of primary tumor Tis: Carcinoma in situ : intraepithelial or invasion of the lamina propria : Tumor invades submucosa T2: Tumor invades muscularis propria T3: Tumor invades through the muscularis propria into the subserosa, or into nonperitonealized pericolic or perirectal tissues T4: Tumor directly invades other organs or structures, and/or perforates visceral peritoneum Regional lymph nodes (N) NX: Regional nodes cannot be assessed N0: No regional lymph node metastasis : Metastasis in 1 to 3 regional lymph nodes N2: Metastasis in 4 or more regional lymph nodes Distant metastasis (M) MX: Distant metastasis cannot be assessed M0: No distant metastasis M1: Distant metastasis Stage Stage Stage Stage Stage 0 Tis, N0, M0 I, N0, M0 T2, N0, M0 IIA T3, N0, M0 IIB T4, N0, M0 IIIA,, M0 T2,, M0 IIIB T3,, M0 T4,, M0 IIIC Any T, N2, M0 IV Any T, Any N, M1 References 1. Colon and rectum. In: American Joint Committee on Cancer.: AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer, 2002, pp 113-124.

Lot. No : 120212100411 Fig3. RT-PCR for GAP3DH 326.64 111.83 260/280 2 1.97 AGE: 56 Sex: Female Stage: T3M1 1.Rectum, segmental resection: Ulceroinfiltrating adenocarcinoma, moderately differentiated, extending into perirectal fat tissue with 1) occasional lympho vascular permeation and frequent perineural invasion. 2) resection margins, proximal and distal: Free of tumor. 3) resection margin, lateral: Extension of tumor. 4) regional lymph nodes, principal (1/1), perirectal (1/18) : (2/19): 5) metastatic adenocarcinoma in 2 out of 19 nodes with perinodal tumor extension. * Post operation: chemotheraphy (5FU,Levorin) * Comment: hypothyroidism

Lot. No : 120212100921 Skin Fig 2. Scanned images for H&E stained slides. Skin Fig3. RT-PCR for GAP3DH Sample : Serial 10 sections of Skin 1055.78 369.06 97 260/280 2 1.97 1.96 AGE: 44 Sex: Female Stage: T2N0M0 1.Rectum, Mile's operation: Adenocarcinoma, well differentiated, fungating type 1) extension to proper muscle layer without invasion into perirectal fat and vaginal wall 2) marked peritumoral inflammatory infiltrate and fibrosis. 3) resection margins, proximal and distal: Free of tumor. 4) regional lymph node, principal (0/0), perirectal (0/26): Free of tumor.

Lot. No : 120213020411 571.93 640.14 260/280 1.94 2 AGE: 69 Sex: Male Stage: T3N2M0 1.Rectum with perirectal soft tissue, Miles' operation: Ulcerofungating adenocarcinoma, moderately differentiated, 1) size: 4x3.8cm 2) infiltrating growth 3) penetration of muscle layer and extension to perirectal soft tissue 4) vascular and perineural invasion 5) intact proximal and distal(anus) resection margins but extension to lateral one 6) metastasis to 8 out of 41 perirectal lymph nodes (perirectal (8/32), principal (0/9)) 7) two tubular adenomas with low to focal high grade dysplasia the surrounding mucosa * Post operation: adjuvant chemotheraphy (5Fu, Leorin) * Comments: with hepatocellular carcinoma

Lot. No : 120213061121 131.06 497.64 260/280 1.97 1.95 AGE: 72 Sex: Male Stage: T3N0M0 1.Rectum, low anterior resection: Adenocarcinoma, moderately differentiated, ulcerative type with 1) extension to the perirectal fat tissue. 2) resection margins, proximal, distal and lateral: Free of tumor. 3) lymph nodes, regional (0/16): Free of tumor. 2.Soft tissue, separately submitted as principal node: Free of tumor. * Comments: smoking 50 years

Lot. No : 120214022031 Fig3. RT-PCR for GAP3DH 496.99 147.52 260/280 1.93 1.96 AGE: 38 Sex: Male Stage: T3N2M0 1. Rectum, low anterior resection: Ulcerofungating adenocarcinoma moderately differentiated with 1) size: 6.2x5.2cm 2) infiltrative growth 3) extension to perirectal soft tissue but intact lateral resection margin 4) no vascular and perineural invasion 5) intact proximal and distal resection margins 6) metastasis to 5 out of 29 perirectal lymph nodes ( principal (0/9) and perirectal (5/20) ) MSI(Microsatellite instability) test Marker Name bat26 D5S346 bat25 D17S250 D2S123 Microsatellite No No No No No MSS instability Allelic uninformative uninformative No (0.79) No (1.28) Imbalance * Post operation: adjuvant chemotheraphy (5FU,Levorine)

Lot. No : 120212090441 Stomach Stomach Fig3. RT-PCR for GAP3DH Stomach 224.58 356.39 165.77 260/280 1.93 1.92 2 AGE: 73 Sex: Male Stage: T3N2M0 1.Rectum with perirectal soft tissue, Mile's operation: Ulceroinfiltrative adenocarcinoma, moderately differentiated, 1) size: 4.5x2.3cm. 2) infiltrative growth. 3) penetration of muscle layer and extension to perirectal fatty tissue. 4) perineural invasion but not vascular invasion. 5) intact proximal and distal resection margins. 6) metastasis to 5 out of 24 regional lymph nodes ( principal (0/1), perirectal(5/23) ). 7) surrounding mucosa showing tubular adenomas with low grade dysplasia. 2.Artery, clinically right internal iliac, segmental resection: Atherosclerosis. * Post operation: adjuvant chemotheraphy (5FU,Levorin)

A916: rectum: adenocacinoma Lot. No : 120212100211 153.52 451.06 260/280 2.01 1.97 AGE: 69 Sex: Female Stage: T3M0 1.Rectum, segmental resection: Adenocarcinoma, moderately differentiated, ulceroinfiltrative type 1) extension to perirectal fat tissue without vascular permeation or perineural invasion. 2) resection margins, proximal and distal: Free of tumor. 3) esection margin, lateral: see note. 4) regional lymph nodes, principal (0/1), perirectal (1/17) : (1/18): Metastatic adenocarcinoma in one out of 18 nodes with perinodal tumor extension. Note: The tumor is very close to the lateral margin (about 0.6mm).

Lot. No : 1202102070931 21.9 53.91 260/280 1.92 1.91 AGE: 60 Sex: Male Stage: T3M0 1.Rectum, anterior resection: Adenocarcinoma, moderately differentiated, 1) ulcerofungating type. 2) size: 4.5x4.0cm 3) extension to perirectal fat tissue. 4) very close to lateral margin (within 0.5mm). 5) no lymphovascular permeation. 6) Tubular adenoma with low grade dysplasia. 7) regional lymph nodes, principal (0/2), peri-rectal (2/24):(2/26): Tumor metastasis in 2 out of 26 nodes. 8) separately submitted nodes with perinodal tumor extension: Tubular adenoma with low grade dysplasia. * Post operation : adjuvant chemotheraphy (5FU, Leucovorin). * Comments: alcohol

A916 rectum: adenocarcinoma Lot. No : 1202202070941 N 104.01 114.64 260/280 1.92 1.93 AGE: 68 Sex: Female Stage: T3N0M1 1.Rectum, anterior resection: Adenocarcinoma, moderately differentiated, ulcerofungating type 1) extension to perirectal fat tissue and very close to serosa (<0.8mm). 2) resection margins, proximal and distal: Free of tumor. 3) regional lymph nodes, principal (0/10), perirectal (0/29):(0/39): Free of tumor.

Lot. No : 1202102073121 326.76 398.64 260/280 1.95 1.93 AGE: 56 Sex: Male Stage: T3N0M0 1.Rectum, Hartmann's operation: Adenocarcinoma, moderately differentiated, fungating type, 1) extension to the peirectal fat tissue and extensive lymphatic invasion. 2) resection margins, proximal and distal: Free of tumor. 3) lymph nodes, regional(0/11) and principal(0/0): Free of tumor metastasis in all 11 nodes. * Post operation: adjuvant chemotheraphy (5FU,Leucovorin)

A916: colon(rectum): adenocarcinoma Lot. No : 1202102082731 for H&E stained slides 239.55 183.01 260/280 1.95 1.95 AGE: 62 Sex: Female Stage: T2N0M0 1.Total colorectum and terminal ileum, total colectomy: Fungating adenocarcinoma, moderately differentiated, arising from adenomatous polyp 1) size: 3.5x3cm. 2) expanding growth. 3) involving submucosal space and extending to proper muscle layer. 4) intact proximal and distal resection margins. 5) no metastasis to regional pericolic lymph nodes (0/72) and principal lymph node(0/0). 6) non-neoplastic mucosa showing multiple (about 30) adenomatous polyp i ncluding tubular and tubulovillous adenomas with low to high grade dysplasia. 2.Appendix, appendectomy, separately submitted: Free from tumor extension.

Lot. No : 1202102032420 12.99 260/280 1.86 AGE: 65 Sex: F Stage: T3N0M0 1.Rectum, segmental resection: Adenocarcinoma, well differentiated, ulceroinfiltrative, with 1) extension to the perirectal fat tissue 2) occasional lymphatic invasion. 3) resection margins, proximal and distal: Free of tumor. 4) lymph nodes, regional (0/21) and principal (0/2): Free of tumor metastasis in all 23 nodes. * Post operation :adjuvant chemotheraphy